nutrition_urologie http://feed.informer.com/digests/KYCXVPC7VQ/feeder nutrition_urologie Respective post owners and feed distributors Thu, 04 Apr 2019 19:57:20 +0000 Feed Informer http://feed.informer.com/ Implementation of malnutrition quality improvement reveals opportunities for better nutrition care delivery for hospitalized patients http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&MODE=ovid&PAGE=fulltext&NEWS=n&D=emexb&AUTOALERT=293276628%7c1 nutrition_uro_embase urn:uuid:547dff1a-76db-a675-4eb8-7e704e0a58b3 Sat, 07 May 2022 08:46:32 +0000 <div class="field" > <strong>Author Names:</strong> <span>Wills-Gallagher J.,Kerr K.W.,Macintosh B.,Valladares A.F.,Kilgore K.M.,Sulo S.</span> </div> <div class="field" > <strong>Database Source:</strong> <span>Embase Weekly Updates</span> </div> <div class="field" > <strong>Journal Title:</strong> <span>Journal of Parenteral and Enteral Nutrition,Journal of Parenteral and Enteral Nutrition</span> </div> <div class="field" > <strong>Article Title:</strong> <span><a href="http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;MODE=ovid&amp;PAGE=fulltext&amp;NEWS=n&amp;D=emexb&amp;AUTOALERT=293276628%7c1">Implementation of malnutrition quality improvement reveals opportunities for better nutrition care delivery for hospitalized patients</a></span> </div> <div class="field" > <strong>Year:</strong> <span>2022</span> </div> <div class="field" > <strong>Issue:</strong> <span>1</span> </div> <div class="field" > <strong>Volume:</strong> <span>46</span> </div> <div class="field" > <strong>Abstract:</strong> <span>Background: Gaps in hospital-based nutrition care practices and opportunities to improve care of patients at risk of malnutrition or malnourished have been demonstrated by several US hospitals implementing quality improvement (QI) projects. This study examined the impact of nutrition care process improvements focused on better documentation of identification and diagnosis of malnutrition in 5 hospital services and differences between nutritionally targeted vs nontargeted services. &lt;br/&gt;Method(s): Data on malnutrition risk screening, nutrition assessment, malnutrition diagnosis, and nutrition care plan delivery were collected from 32,723 hospital encounters for patients admitted to the intensive care unit, pulmonology, oncology, urology, and general medicine services (targeted) as well as the rest of the nontargeted hospital services between 2017 and 2019. &lt;br/&gt;Result(s): Higher rates of morbidity in targeted service patients compared with those in the patient population admitted in the nontargeted services were observed, including higher rates of malnutrition risk (37.43% vs 19.16%, P &lt;.001), higher rates of moderate and severe malnutrition first identified by a registered dietitian nutritionist (20.27% vs 9.67%, P &lt;.001), and malnutrition diagnosis confirmed by an admitting physician (16.72% vs 6.74%, P &lt;.001). &lt;br/&gt;Conclusion(s): The findings suggest sustained improvements in confirmed rates of malnutrition identification and diagnosis are achievable. Targeting malnutrition QI efforts to hospital services with higher patient morbidity is an effective method for improving malnutrition diagnosis, in particular in hospitals with limited resources, which in turn can result in improved nutrition care delivery.&lt;br/&gt;Copyright &amp;#xa9; 2021 The Authors. Journal of Parenteral and Enteral Nutrition published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition</span> </div> Prognostic impact of prognostic nutritional index on renal cell carcinoma: A meta-analysis of 7,629 patients https://pubmed.ncbi.nlm.nih.gov/35312690/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:ccdeb664-877a-c7ee-cc58-6f3c5c56614a Mon, 21 Mar 2022 00:00:00 +0000 CONCLUSION: PNI is an independent prognostic indicator of survival and associated with Fuhrman grade, T stage, sarcomatoid differentiation, and tumor necrosis in patients with RCC. <div><p style="color: #4aa564;">PLoS One. 2022 Mar 21;17(3):e0265119. doi: 10.1371/journal.pone.0265119. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Prognostic nutritional index (PNI) is a parameter which reflects nutritional and inflammatory status. The prognostic value of PNI in renal cell carcinoma (RCC) remains in debate. The aim of this study is to evaluate the prognostic value and clinicopathological features of PNI in RCC.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A literature search was performed in the databases of PubMed, Embase, Web of Science, and Cochrane Library. Hazard ratios (HRs), odds ratios (ORs), and 95% confidence intervals (CIs) were extracted for meta-analysis. The association between PNI and overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), progression-free survival (PFS), recurrence-free survival (RFS), and clinicopathological factors were evaluated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Eleven studies involving 7,629 patients were included for meta-analysis. A decreased PNI was shown to be a significant predictor of worse OS (HR = 2.00, 95%CI = 1.64-2.42, p&lt;0.001), CSS (HR = 2.54, 95%CI = 1.61-4.00, p&lt;0.001), and DFS/PFS/RFS (HR = 2.12, 95%CI = 1.82-2.46, p&lt;0.001) in RCC. Furthermore, a low PNI was correlated with Fuhrman grade III-IV (OR = 1.96, 95%CI = 1.27-3.02, p = 0.002), T stage T3-T4 (OR = 2.21, 95%CI = 1.27-3.87, p = 0.005), presence of sarcomatoid differentiation (OR = 5.00, 95%CI = 2.52-9.92, p&lt;0.001), and presence of tumor necrosis (OR = 3.63, 95%CI = 2.54-5.19, p&lt;0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: PNI is an independent prognostic indicator of survival and associated with Fuhrman grade, T stage, sarcomatoid differentiation, and tumor necrosis in patients with RCC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35312690/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">35312690</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8936492/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8936492</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0265119>10.1371/journal.pone.0265119</a></p></div> Preoperative nutritional evaluation of prostate cancer patients undergoing laparoscopic radical prostatectomy https://pubmed.ncbi.nlm.nih.gov/35108317/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:0cff0b2b-e059-f4c8-9bd9-f117499557fa Wed, 02 Feb 2022 00:00:00 +0000 CONCLUSION: GNRI is an effective and reliable tool for evaluation of preoperative nutritional status of prostate cancer patients. The findings showed that GNRI is correlated with postoperative recovery and complications, and is an effective predictive marker. <div><p style="color: #4aa564;">PLoS One. 2022 Feb 2;17(2):e0262630. doi: 10.1371/journal.pone.0262630. eCollection 2022.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND OBJECTIVE: Prostate cancer (PCa) is one of the most common malignant tumors in men. Geriatric Nutritional Risk Index (GNRI) is an objective index for evaluating nutritional status of elderly people over 65 years old. The aim of the current study was to explore the correlation and predictive value between GNRI and postoperative recovery and complications in PCa patients undergoing laparoscopic radical prostatectomy (LRP).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Taking 98 as the GNRI boundary value, 96 PCa patients (aged≥65 y) undergoing LRP in the Department of Urology, Affiliated Hospital of North Sichuan Medical College from January 2018 to December 2020 were grouped into malnutrition group (MNg, 34 patients, 35.4%) and normal nutrition group (NNg, 62 patients, 64.6%). Basic information, laboratory examination indexes, operation conditions, postoperative complications and postoperative recovery indexes of patients were recorded and retrospectively analyzed. Clavien-Dindo Classification System (CDCS) was used to assess postoperative complications. T-test was used to analyze differences between the two groups. ROC curve was generated to determine the predictive value of GNRI for postoperative complications.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Percentage of complications was significantly higher in MNg group compared with that in NNg group (P &lt; 0.01). The average grade based on CDCS was significantly lower in NNg group compared with that in MNg group (P &lt; 0.01). Body weight, Body Mass Index (BMI), preoperative hemoglobin value (HGB), serum albumin (ALB) values of MNg and NNg were significantly positively correlated with GNRI (P&lt;0.01). Incidence and severity of postoperative complications of MNg patients were significantly higher compared with those of NNg patients (P&lt;0.05). Average hospitalization cost of MNg patients was higher in MNg patients compared with that of NNg patients (P&lt;0.05). Duration of post-anesthesia care unit (PACU), duration of antibiotic use and duration of indwelling drainage tube were longer in MNg patients compared with those in NNg patients (P&lt;0.05). Furthermore, volume of indwelling drainage tube was higher in MNg patients compared with that in NNg patients (P&lt;0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: GNRI is an effective and reliable tool for evaluation of preoperative nutritional status of prostate cancer patients. The findings showed that GNRI is correlated with postoperative recovery and complications, and is an effective predictive marker.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35108317/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">35108317</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8809613/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8809613</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0262630>10.1371/journal.pone.0262630</a></p></div> Implementation of malnutrition quality improvement reveals opportunities for better nutrition care delivery for hospitalized patients. https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=155254087&site=ehost-live S3 AND S7 AND S12 on 2019-04-04 03:57 PM urn:uuid:a72a5737-8688-42db-556c-1c6e8bdd93f4 Sat, 01 Jan 2022 05:00:00 +0000 JPEN Journal of Parenteral & Enteral Nutrition; 01/01/2022<br/>(AN 155254087); ISSN: 01486071<br/>CINAHL Complete Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications https://pubmed.ncbi.nlm.nih.gov/34960023/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:6969c1f4-6800-d74a-4918-f6e91e21cc15 Tue, 28 Dec 2021 00:00:00 +0000 CONCLUSIONS: NAC-related nutritional deterioration is associated with increased risk of complications after RC. Our results hint towards the need for nutritional intervention during NAC prior to RC. <div><p style="color: #4aa564;">Nutrients. 2021 Dec 14;13(12):4471. doi: 10.3390/nu13124471.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer (MIBC). Neoadjuvant chemotherapy (NAC) is associated with improved patient survival. The impact of NAC on nutritional status is understudied, while the association between malnutrition and poor surgical outcomes is well known. This study aims to examine the association between NAC, nutritional status impairment, and post-operative morbidity.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIALS AND METHODS: We included MIBC patients who underwent RC and received NAC from multiple academic centers in Israel. Cross-sectional imaging was used to measure the psoas muscle area and normalized it by height (smooth muscle index, SMI). Pre- and post-NAC SMI difference was calculated (represents nutritional status change). The primary outcomes were post-RC ileus, infection, and a composite outcome of any complication. Logistic regression models were fit to identify independent predictors of the outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ninety-one patients were included in the study. The median SMI change was -0.71 (-1.58, -0.06) cm<sup>2</sup>/m<sup>2</sup>. SMI decline was significantly higher in patients with post-RC complications (-18 vs. -203, <i>p</i> &lt; 0.001). SMI change was an independent predictor of all complications, ileus, infection, and other complications. The accuracy of SMI change for predicting all complications, ileus, infection, and other complications was 0.85, 0.87, 0.75, and 0.86, respectively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: NAC-related nutritional deterioration is associated with increased risk of complications after RC. Our results hint towards the need for nutritional intervention during NAC prior to RC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34960023/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34960023</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8708207/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8708207</a> | DOI:<a href=https://doi.org/10.3390/nu13124471>10.3390/nu13124471</a></p></div> Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma https://pubmed.ncbi.nlm.nih.gov/34917092/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:2583bc71-3ec7-cf3a-8f2c-6862349c2e7e Fri, 17 Dec 2021 00:00:00 +0000 CONCLUSION: The CONUT score, an easily measurable immune-nutritional biomarker, may provide useful prognostic information in HIV-related RCC. <div><p style="color: #4aa564;">Front Immunol. 2021 Nov 30;12:778746. doi: 10.3389/fimmu.2021.778746. eCollection 2021.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: In recent years, the controlled nutritional status (CONUT) score has been widely recognized as a new indicator for assessing survival in patients with urological neoplasms, including renal, ureteral, and bladder cancer. However, the CONUT score has not been analyzed in patients with HIV-related urological neoplasms. Therefore, we aimed to evaluate the prognostic significance of the CONUT score in patients with HIV-related renal cell carcinoma (RCC).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A total of 106 patients with HIV-related RCC were recruited from four hospitals between 2012 and 2021, and all included patients received radical nephrectomy or partial nephrectomy. The CONUT score was calculated by serum albumin, total lymphocyte counts, and total cholesterol concentrations. Patients with RCC were divided into two groups according to the optimal cutoff value of the CONUT score. Survival analysis of different CONUT groups was performed by the Kaplan-Meier method and a log rank test. A Cox proportional risk model was used to test for correlations between clinical variables and cancer-specific survival (CSS), overall survival (OS), and disease-free survival (DFS). Clinical variables included age, sex, hypertension, diabetes, tumor grade, Fuhrman grade, histology, surgery, and CD4+ T lymphocyte count.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULT: The median age was 51 years, with 93 males and 13 females. At a median follow-up of 41 months, 25 patients (23.6%) had died or had tumor recurrence and metastasis. The optimal cutoff value for the CONUT score was 3, and a lower CONUT score was associated with the Fuhrman grade (P=0.024). Patients with lower CONUT scores had better CSS (HR 0.197, 95% CI 0.077-0.502, P=0.001), OS (HR 0.177, 95% CI 0.070-0.446, P&lt;0.001) and DFS (HR 0.176, 95% CI 0.070-0.444, P&lt;0.001). Multivariate Cox regression analysis indicated that a low CONUT score was an independent predictor of CSS, OS and DFS (CSS: HR=0.225, 95% CI 0.067-0.749, P=0.015; OS: HR=0.201, 95% CI 0.061-0.661, P=0.008; DFS: HR=0.227, 95% CI 0.078-0.664, P=0.007). In addition, a low Fuhrman grade was an independent predictor of CSS (HR 0.192, 95% CI 0.045-0.810, P=0.025), OS (HR 0.203, 95% CI 0.049-0.842, P=0.028), and DFS (HR 0.180, 95% CI 0.048-0.669, P=0.010), while other factors, such as age, sex, hypertension, diabetes, tumor grade, histology, surgery, and CD4+ T lymphocyte count, were not associated with survival outcome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The CONUT score, an easily measurable immune-nutritional biomarker, may provide useful prognostic information in HIV-related RCC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34917092/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34917092</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8669761/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8669761</a> | DOI:<a href=https://doi.org/10.3389/fimmu.2021.778746>10.3389/fimmu.2021.778746</a></p></div> The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis https://pubmed.ncbi.nlm.nih.gov/34854753/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:294a59be-2130-14b3-63da-d257ab1bae4a Thu, 02 Dec 2021 00:00:00 +0000 CONCLUSIONS: We demonstrate that nutritional status evaluated by GNRI predicts 30-day complications after RC. <div><p style="color: #4aa564;">J Urol. 2022 Apr;207(4):797-804. doi: 10.1097/JU.0000000000002342. Epub 2021 Dec 2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: The Geriatric Nutritional Risk Index (GNRI) is a simple screening tool to predict nutrition-related risk of morbidity and mortality in older patients. We assessed whether preoperative GNRI was associated with 30-day complications after radical cystectomy (RC).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIALS AND METHODS: Using the American College of Surgeons National Surgical Quality Improvement Program database, we identified patients 65 years or older who underwent RC for the treatment of bladder cancer between 2007 and 2019. Patients were dichotomized into at-risk (GNRI ≤98) or no-risk (GNRI &gt;98) groups. Using propensity score matching, the 2 groups were compared for baseline differences and 30-day outcomes. We evaluated GNRI as an independent predictor of postoperative complications using multivariable logistic regression analysis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: We identified 2,926 patients eligible for analysis. After propensity score matching, patients in the at-risk GNRI group had higher rates of any complication (p=0.017), blood transfusion (p=0.002), extended length of stay (p=0.004) and nonhome discharge (p &lt;0.001). Multivariable logistic regression analysis revealed that a decreasing GNRI is an independent prognostic factor for mortality (OR 1.05, 95% CI 1.01-1.08, p=0.009), blood transfusion (OR 1.03, 95% CI 1.02-1.04, p &lt;0.001), pneumonia (OR 1.04, 95% CI 1.01-1.07, p=0.013), extended length of stay (OR 1.03, 95% CI 1.02-1.05, p &lt;0.001) and nonhome discharge (OR 1.04, 95% CI 1.03-1.06, p &lt;0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We demonstrate that nutritional status evaluated by GNRI predicts 30-day complications after RC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34854753/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34854753</a> | DOI:<a href=https://doi.org/10.1097/JU.0000000000002342>10.1097/JU.0000000000002342</a></p></div> The prognostic nutritional index predicts the biochemical recurrence of patients treated with robot-assisted laparoscopic radical prostatectomy https://pubmed.ncbi.nlm.nih.gov/34783377/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:a84b3261-a6ff-82e6-f6be-fcae138a2b37 Tue, 16 Nov 2021 00:00:00 +0000 CONCLUSION: PNI is an independent prognostic factor for predicting BCR in patients treated with RALP. The incorporation of the PNI into risk assessments may provide additional prognostic information. <div><p style="color: #4aa564;">Prostate. 2022 Feb;82(2):221-226. doi: 10.1002/pros.24263. Epub 2021 Nov 16.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the prognostic nutritional index (PNI) in predicting the biochemical recurrence (BCR) of patients treated with robot-assisted laparoscopic radical prostatectomy (RALP).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The clinical data of 136 patients treated with RALP in the Department of Urology, The Third Xiangya Hospital of Central South University were retrospectively analyzed. The endpoint of observation was BCR. The area under the receiver operating characteristic (ROC) curve was evaluated to determine the optimal cutoff value of PNI. The correlation of the PNI with BCR was estimated using Kaplan-Meier analysis and Cox proportional hazards model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The optimal cutoff value of the PNI was 46.03 according to the ROC curve. (95% confidence interval: 0.604-0.805, Youden index = 0.401, sensitivity = 82.5%, specificity = 57.6%, p &lt; 0.01). Multivariate Cox analysis showed that clinical staging, prostate-specific antigen, and PNI were independent prognostic factors for predicting BCR in patients treated with RALP.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: PNI is an independent prognostic factor for predicting BCR in patients treated with RALP. The incorporation of the PNI into risk assessments may provide additional prognostic information.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34783377/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34783377</a> | DOI:<a href=https://doi.org/10.1002/pros.24263>10.1002/pros.24263</a></p></div> First Report of Oncological Outcome and Prognostic Analysis in a First-Line Setting of Short Hydration Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Urothelial Carcinoma. https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152610758&site=ehost-live S3 AND S7 AND S12 on 2019-04-04 03:57 PM urn:uuid:fff7b0b2-353b-6c35-68ab-236e7539fa9b Fri, 01 Oct 2021 04:00:00 +0000 Oncology; 10/01/2021<br/>(AN 152610758); ISSN: 00302414<br/>CINAHL Complete Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis https://pubmed.ncbi.nlm.nih.gov/34253447/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:a1286b95-9d54-8508-d7cd-ebc7dcac67b2 Tue, 13 Jul 2021 00:00:00 +0000 CONCLUSION: This meta-analysis indicated that lower PNI was a negative prognostic factor and associated with tumor progression and poorer survival of patients with RCC. Therefore, PNI could be a potential prognostic predictor of treatment outcomes for patients with RCC. <div><p style="color: #4aa564;">Urol Oncol. 2021 Oct;39(10):623-630. doi: 10.1016/j.urolonc.2021.05.028. Epub 2021 Jul 10.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: To perform a systematic review and meta-analysis of the Prognostic Nutritional Index (PNI) as a prognostic factor for renal cell carcinoma (RCC).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MATERIALS AND METHODS: Eligible studies that evaluated the prognostic impact of pretreatment PNI in RCC patients were identified by comprehensive searching the electronic databases PubMed, Cochrane Central Search library, and EMBASE. The end points were overall/cancer-specific survival (OS/CSS) and recurrence-free/disease-free survival (RFS/DFS). Meta-analysis using random-effects models was performed to calculate hazard ratios (HRs) with 95 % confidence intervals (CIs).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In total, 9 retrospective, observational, case-control studies involving 5,976 patients were included for final analysis. Eight studies evaluated OS/CSS, and 5 evaluated RFS/DFS. Our results showed that lower PNI was significantly associated with unfavorable OS/CSS (HR = 1.68, 95% CI 1.44-1.96, P &lt; 0.001, I<sup>2</sup> = 9.2%, P = 0.359) and RFS/DFS (HR = 1.98, 95% CI 1.57-2.50, P &lt; 0.001, I<sup>2</sup> = 18.2%, P = 0.299) in patients with RCC. Subgroup and meta-regression analysis based on ethnicity, study sample size, presence of metastasis, PNI cut-off value, Newcastle-Ottawa quality assessment scale (NOS) score, and gender ratio all showed that lower PNI was associated with poorer OS/CSS and RFS/DFS. Funnel plots and Egger's tests indicated significant publication bias in OS/CSS (P = 0.001), but not in RFS/DFS (P = 0.757).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This meta-analysis indicated that lower PNI was a negative prognostic factor and associated with tumor progression and poorer survival of patients with RCC. Therefore, PNI could be a potential prognostic predictor of treatment outcomes for patients with RCC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34253447/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34253447</a> | DOI:<a href=https://doi.org/10.1016/j.urolonc.2021.05.028>10.1016/j.urolonc.2021.05.028</a></p></div> Prognostic significance of the controlling nutritional status score in patients with metastatic renal cell carcinoma diagnosed before an era of first-line immune-oncology combination therapies https://pubmed.ncbi.nlm.nih.gov/34075403/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:9cbe0de0-31ad-3c96-0bab-2bbc578185a7 Wed, 02 Jun 2021 00:00:00 +0000 CONCLUSION: The controlling nutritional status score may serve as a prognostic biomarker objectively reflecting the general physical condition of patients with metastatic renal cell carcinoma treated with or without first-line interferon or tyrosine kinase inhibitor in terms of nutritional and immuno-inflammatory status. <div><p style="color: #4aa564;">Jpn J Clin Oncol. 2021 Oct 5;51(10):1570-1576. doi: 10.1093/jjco/hyab078.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To explore the prognostic role of the controlling nutritional status score in patients with metastatic renal cell carcinoma.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We retrospectively analyzed 107 patients with metastatic renal cell carcinoma who received their diagnosis between 2007 and 2018 and were treated with or without a first-line interferon or tyrosine kinase inhibitor at a single cancer center. The controlling nutritional status score was based on values for albumin, lymphocyte count and total cholesterol at the metastatic renal cell carcinoma diagnosis. Association of the controlling nutritional status score and clinical variables, including the Memorial Sloan-Kettering Cancer Center and the International Metastatic Renal Cell Carcinoma Database Consortium risk classifications, with overall survival was examined using the Cox proportional hazard model. Predictive accuracy of the prognostic factors was assessed using Harrell's concordance index.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: First-line interferon and tyrosine kinase inhibitor were given to 48 (45%) and 41 (38%) patients, respectively, and 28 (26%) and 33 (31%) patients underwent cytoreductive nephrectomy and metastasectomy, respectively. During follow-up (median: 36.3 months), 64 patients died. The median controlling nutritional status score was 2 (range: 0-8). A controlling nutritional status score ≥ 2 was significantly associated with shorter overall survival (P &lt; 0.01) independently of the Memorial Sloan-Kettering Cancer Center and International Metastatic Renal Cell Carcinoma Database Consortium risk classifications. Integration of the controlling nutritional status score into the Memorial Sloan-Kettering Cancer Center and International Metastatic Renal Cell Carcinoma Database Consortium risk classifications improved concordance index from 0.702 to 0.770 and from 0.698 to 0.749, respectively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The controlling nutritional status score may serve as a prognostic biomarker objectively reflecting the general physical condition of patients with metastatic renal cell carcinoma treated with or without first-line interferon or tyrosine kinase inhibitor in terms of nutritional and immuno-inflammatory status.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34075403/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34075403</a> | DOI:<a href=https://doi.org/10.1093/jjco/hyab078>10.1093/jjco/hyab078</a></p></div> Prognostic Significance of Prognostic Nutritional Index in Patients with Renal Cell Carcinoma: A Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/34060398/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:6d365e1e-62e9-0d3c-e307-c1514a8bbdaf Tue, 01 Jun 2021 00:00:00 +0000 The prognostic nutrition index (PNI), based on the serum lymphocyte counts and albumin levels, has been introduced as a prognostic factor in various cancer. In the present study, we explore the prognostic significance of PNI in patients with renal cell carcinoma (RCC). A literature search of all publications was conducted using the Cochrane library, PubMed and Embase databases from inception to April 2020. A total of 12 studies consisting of 7,391 patients were enrolled in the present study. We... <div><p style="color: #4aa564;">Nutr Cancer. 2022;74(3):860-868. doi: 10.1080/01635581.2021.1931702. Epub 2021 Jun 1.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The prognostic nutrition index (PNI), based on the serum lymphocyte counts and albumin levels, has been introduced as a prognostic factor in various cancer. In the present study, we explore the prognostic significance of PNI in patients with renal cell carcinoma (RCC). A literature search of all publications was conducted using the Cochrane library, PubMed and Embase databases from inception to April 2020. A total of 12 studies consisting of 7,391 patients were enrolled in the present study. We found that low pretreatment PNI is significantly correlated to poor survival, including overall survival (OS) (<i>P</i> &lt; 0.001), cancer-specific survival (CSS) (<i>P</i> = 0.002), progression-free survival/recurrence-free survival/disease-free survival (PFS/RFS/DFS) (<i>P</i> &lt; 0.001). The age (<i>P</i> &lt; 0.001), clear cell histology (<i>P</i> = 0.044), T3-T4 (<i>P</i> = 0.049), and Fuhrman grade 3-4 (<i>P</i> = 0.024) were significantly differed in the low and high pretreatment PNI group. In summary, low pretreatment PNI was associated with adverse clinicopathological features in patients with RCC. Besides, low pretreatment PNI was also an unfavorable factor of OS, CSS, and PFS/RFS/DFS in RCC patients, which could serve as an unfavorable factor. More studies with large participants are required to verify our results.Supplemental data for this article is available online at https://doi.org/10.1080/01635581.2021.1931702.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34060398/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34060398</a> | DOI:<a href=https://doi.org/10.1080/01635581.2021.1931702>10.1080/01635581.2021.1931702</a></p></div> Controlling Nutritional Status Score Evaluates Prognosis in Patients With Non-Muscle Invasive Bladder Cancer https://pubmed.ncbi.nlm.nih.gov/34060373/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:75a2b1e5-bd5c-4fcb-8018-488db57f4740 Tue, 01 Jun 2021 00:00:00 +0000 CONCLUSION: Therefore, the Controlling Nutritional Status score could be a simple, cost-effective, and reliable predictor of prognoses among of patients with non-muscle-invasive bladder cancer. <div><p style="color: #4aa564;">Cancer Control. 2021 Jan-Dec;28:10732748211021078. doi: 10.1177/10732748211021078.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: We investigated the clinical value of the Controlling Nutritional Status score in evaluating the prognosis of patients with non-muscle invasive bladder cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted a retrospective analysis of the clinical data of 88 patients with non-muscle invasive bladder cancer who underwent transurethral resection of bladder tumor or partial cystectomy between January 2011 and May 2015 in a single center. The patients were divided into groups base on high (&gt;1) and low (≤1) Controlling Nutritional Status score.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Clinical and demographic data of the patient groups were analyzed using the Kaplan-Meier method and log-rank test to generate survival curves. Univariate and multivariate analyses were conducted using the Cox proportional hazard model. Among the participants, the male-to-female ratio was 70:18 and median age was 64.5 years (range, 25-84 years). The numbers of patients with Controlling Nutritional Status score of 0, 1, 2, 3, 4, 5, and 6 were 26 (29.55%), 21 (23.86%), 20 (22.73%), 12 (13.64%), 5 (5.68%), 1 (1.14%), and 3 (3.41%), respectively. The 5-year recurrence rate was 29 out of 88 patients (32.95%). The recurrence-free survival of the high-score group was significantly lower than that of the low-score group (<i>P</i> &lt; 0.001). On univariate analysis, age, smoking history, Controlling Nutritional Status score, depth of tumor invasion, pathological grade, and tumor diameter were related to the prognosis of patients with non-muscle invasive bladder cancer. On multivariate analysis, the Controlling Nutritional Status score (hazard ratio, 4.938; 95% confidence interval, 1.392-17.525; <i>P</i> = 0.013) was an independent factor affecting the recurrence-free survival of patients with non-muscle-invasive bladder cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Therefore, the Controlling Nutritional Status score could be a simple, cost-effective, and reliable predictor of prognoses among of patients with non-muscle-invasive bladder cancer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34060373/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">34060373</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8204588/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8204588</a> | DOI:<a href=https://doi.org/10.1177/10732748211021078>10.1177/10732748211021078</a></p></div> Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy https://pubmed.ncbi.nlm.nih.gov/33788756/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:a88a00fa-1f12-6085-be69-7dcbc68e5d06 Wed, 31 Mar 2021 00:00:00 +0000 CONCLUSION: PNI is a useful predictor of prognosis and disease progression in mUC patients receiving pembrolizumab. <div><p style="color: #4aa564;">Anticancer Res. 2021 Mar;41(3):1607-1614. doi: 10.21873/anticanres.14922.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND/AIM: We investigated the prognostic nutritional index (PNI), comprised of lymphocytes and albumin, as a potential prognosticator of metastatic urothelial carcinoma (mUC) patients receiving pembrolizumab.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: Sixty-five patients were retrospectively enrolled and classified as low (&lt;40) and high (≥40) based on pretreatment PNI. Progression-free survival (PFS), overall survival (OS) and response rates were evaluated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In the low PNI group, significantly shorter PFS and OS were observed. PNI was shown to be an independent predictor of PFS and OS in the multivariate analysis. C-index for both PFS and OS improved with the addition of PNI to the model described in the KEYNOTE-045 study. Significantly more patients experienced initial disease progression in the low PNI group.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: PNI is a useful predictor of prognosis and disease progression in mUC patients receiving pembrolizumab.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33788756/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">33788756</a> | DOI:<a href=https://doi.org/10.21873/anticanres.14922>10.21873/anticanres.14922</a></p></div> Clinical significance of prognostic nutritional index in renal cell carcinomas https://pubmed.ncbi.nlm.nih.gov/33725913/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:4f30cd79-308d-3594-d814-44b553df7776 Wed, 17 Mar 2021 00:00:00 +0000 Prognostic nutritional index (PNI) could reflect the nutrition and inflammation status in cancer patients. This study aims to identify the prognostic significance of PNI in patients with renal cell carcinoma (RCC).A total of 694 RCC patients from our institution were included in this study. The prognostic correlation between PNI and overall survival (OS) and recurrence-free survival (RFS) was analyzed respectively using Kaplan-Meier method and univariate and multivariate Cox model. Studies about... <div><p style="color: #4aa564;">Medicine (Baltimore). 2021 Mar 12;100(10):e25127. doi: 10.1097/MD.0000000000025127.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Prognostic nutritional index (PNI) could reflect the nutrition and inflammation status in cancer patients. This study aims to identify the prognostic significance of PNI in patients with renal cell carcinoma (RCC).A total of 694 RCC patients from our institution were included in this study. The prognostic correlation between PNI and overall survival (OS) and recurrence-free survival (RFS) was analyzed respectively using Kaplan-Meier method and univariate and multivariate Cox model. Studies about the association between pretreatment or preoperative PNI and prognosis of RCC were systemically reviewed and a meta-analysis method was performed to further evaluate the pooled prognostic value of PNI in RCC.267 (38.47%) RCC patients had low PNI according to the cut off value (49.08). Low PNI was associated with poor OS (P &lt; .001) and RFS (P &lt; .001), respectively. In the multivariate Cox analysis, PNI was identified to be an independent prognostic factor for OS (hazard ratio [HR] = 2.13, 95%CI: 1.25-3.62, P = .005). Compared to other nutritional indexes, this risk correlation of PNI is better than that of geriatric nutritional risk index (GNRI; HR = 1.19; P = .531), while is no better than that of neutrophil-lymphocyte ratio (NLR; 1/HR = 2.56; P &lt; .001) and platelet-lymphocyte ratio (PLR; 1/HR = 2.85; P &lt; .001) respectively. Meanwhile, additional 4785 patients from 6 studies were included into pooled analysis. For RCC patients who underwent surgery, low preoperative PNI was significantly associated with worse OS (pooled HR = 1.57, 95%CI: 1.37-1.80, P &lt; .001) and worse RFS (pooled HR = 1.69, 95%CI: 1.45-1.96, P &lt; .001). Furthermore, low PNI (&lt;41-51) was also significantly associated with poor OS (HR = 1.78, 95%CI: 1.26-2.53 P &lt; .05) and poor RFS (HR = 2.03, 95%CI: 1.40-2.95, P &lt; .05) in advanced cases treated with targeted therapies.The present evidences show that PNI is an independent prognostic factor in RCC. Low PNI is significant associated with poor prognosis of RCC patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33725913/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">33725913</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7969234/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC7969234</a> | DOI:<a href=https://doi.org/10.1097/MD.0000000000025127>10.1097/MD.0000000000025127</a></p></div> The Controlling Nutritional Status CONUT Score in Patients With Advanced Bladder Cancer After Radical Cystectomy https://pubmed.ncbi.nlm.nih.gov/33622895/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:bf2e7cad-e29b-9673-3688-426f9c6139a4 Wed, 24 Feb 2021 00:00:00 +0000 CONCLUSION: The CONUT score could be an effective predictor for survival and tolerability following RC for advanced BC. <div><p style="color: #4aa564;">In Vivo. 2021 Mar-Apr;35(2):999-1006. doi: 10.21873/invivo.12343.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND/AIM: The impact of the controlling nutritional status (CONUT) score on oncological outcomes after radical cystectomy (RC) for advanced bladder cancer (BC) is unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PATIENTS AND METHODS: We retrospectively evaluated 115 patients who underwent RC for advanced BC at our department between November 2003 and February 2019. The CONUT score was calculated from serum albumin levels, total lymphocyte counts, and total cholesterol levels. Relapse-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) after RC were analyzed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: For the CONUT score, the area under curve was 0.651 and the optimal cut-off value determined using the Youden index was 3. The high CONUT group had significantly shorter RFS, CSS, and OS than the low CONUT group. Multivariate analyses showed that the CONUT score was an independent prognostic factor of RFS, CSS, and OS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The CONUT score could be an effective predictor for survival and tolerability following RC for advanced BC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33622895/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">33622895</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8045070/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">PMC8045070</a> | DOI:<a href=https://doi.org/10.21873/invivo.12343>10.21873/invivo.12343</a></p></div> Influence of nutritional status and frailty phenotype on health-related quality of life of patients with bladder or kidney cancer https://pubmed.ncbi.nlm.nih.gov/33606096/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:ea6866bb-c293-8b71-12bf-e26b78876d89 Fri, 19 Feb 2021 00:00:00 +0000 CONCLUSION: These findings indicate that frailty and malnutrition negatively affect HRQoL of patients with bladder or kidney cancer in several aspects. <div><p style="color: #4aa564;">Support Care Cancer. 2021 Sep;29(9):5139-5150. doi: 10.1007/s00520-021-06058-3. Epub 2021 Feb 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">PURPOSE: This research aimed to assess the impact of nutritional status and frailty in the health-related quality of life (HRQoL) of patients with bladder or kidney cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a cross-sectional study with individuals aged 20 years or older. Frailty phenotype was defined using the criteria of Fried et al. (2001). Patient-Generated Subjective Global Assessment (PG-SGA) classified nutritional status. The European Organization for Research and Treatment of Cancer Quality of life questionnaire Core-30 third version (EORTC QLQ-C30) assessed HRQoL.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Forty-four patients with bladder and 44 with kidney cancer, mostly male, with a mean age of 65.9 and 58.6 years, respectively, were evaluated. Presence of frailty was not different between young and older adults. More than 80% of the robust subjects were well-nourished, while there was a predominance of frail with some degree of malnutrition (p &lt; 0.05). The summary score of HRQoL was worse among the frails than pre-frails and robusts, both in bladder (68.5 vs 86.8 vs 89.5; p = 0.002) and in kidney cancer (54.9 vs 82.9 vs 91.4; p &lt; 0.001), as well as in malnourished compared to well-nourished with bladder (72.9 vs 90.3; p = 0.003) and kidney cancer (69.4 vs 88.3; p = 0.001). After adjusted, frailty and malnutrition continued associated with poor summary score (p &lt; 0.05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: These findings indicate that frailty and malnutrition negatively affect HRQoL of patients with bladder or kidney cancer in several aspects.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33606096/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">33606096</a> | DOI:<a href=https://doi.org/10.1007/s00520-021-06058-3>10.1007/s00520-021-06058-3</a></p></div> The Potential of Prehabilitation in Radical Cystectomy Pathways: Where Are We Now? https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=148862731&site=ehost-live S3 AND S7 AND S12 on 2019-04-04 03:57 PM urn:uuid:a55c896a-0ded-849a-4f6a-443bbb229c5c Mon, 01 Feb 2021 05:00:00 +0000 Seminars in Oncology Nursing; 02/01/2021<br/>(AN 148862731); ISSN: 07492081<br/>CINAHL Complete Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study https://pubmed.ncbi.nlm.nih.gov/33335022/?utm_source=Firefox&utm_medium=rss&utm_campaign=None&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&fc=None&ff=20220517213234&v=2.17.6 pubmed: ((((((("Urology"[MeS... urn:uuid:ea6c3102-220b-5acf-c4d2-b32593b5b4a8 Fri, 18 Dec 2020 00:00:00 +0000 CONCLUSIONS: Although the models performed well for the prediction of incident RCC, they are currently insufficiently powerful to identify individuals at substantial risk of RCC in a general population. <div><p style="color: #4aa564;">Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):507-512. doi: 10.1158/1055-9965.EPI-20-1438. Epub 2020 Dec 17.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Early detection of renal cell carcinoma (RCC) has the potential to improve disease outcomes. No screening program for sporadic RCC is in place. Given relatively low incidence, screening would need to focus on people at high risk of clinically meaningful disease so as to limit overdiagnosis and screen-detected false positives.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Among 192,172 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (including 588 incident RCC cases), we evaluated a published RCC risk prediction model (including age, sex, BMI, and smoking status) in terms of discrimination (C-statistic) and calibration (observed probability as a function of predicted probability). We used a flexible parametric survival model to develop an expanded model including age, sex, BMI, and smoking status, with the addition of self-reported history of hypertension and measured blood pressure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The previously published model yielded well-calibrated probabilities and good discrimination (C-statistic [95% CI]: 0.699 [0.679-0.721]). Our model had slightly improved discrimination (0.714 [0.694-0.735], bootstrap optimism-corrected C-statistic: 0.709). Despite this good performance, predicted risk was low for the vast majority of participants, with 70% of participants having 10-year risk less than 0.0025.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Although the models performed well for the prediction of incident RCC, they are currently insufficiently powerful to identify individuals at substantial risk of RCC in a general population.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPACT: Despite the promising performance of the EPIC RCC risk prediction model, further development of the model, possibly including biomarkers of risk, is required to enable risk stratification of RCC.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33335022/?utm_source=Firefox&utm_medium=rss&utm_content=1LGAx__djGAB9oqIxQoOxiwESsKtqoXpt55P-a7mtCDypE4I9u&ff=20220517213234&v=2.17.6">33335022</a> | DOI:<a href=https://doi.org/10.1158/1055-9965.EPI-20-1438>10.1158/1055-9965.EPI-20-1438</a></p></div>